SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-19-000475
Filing Date
2019-12-16
Accepted
2019-12-16 17:23:59
Documents
81
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnbt103119form10q.htm 10-Q 1145554
2 GRAPHIC image_002.jpg GRAPHIC 5829
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 11919
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 11889
5 EXHIBIT 32 ex32.htm EX-32 3837
  Complete submission text file 0001607062-19-000475.txt   4707411

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE gnbt-20191031.xml EX-101.INS 768393
7 XBRL SCHEMA FILE gnbt-20191031.xsd EX-101.SCH 58581
8 XBRL CALCULATION FILE gnbt-20191031_cal.xml EX-101.CAL 58597
9 XBRL DEFINITION FILE gnbt-20191031_def.xml EX-101.DEF 172947
10 XBRL LABEL FILE gnbt-20191031_lab.xml EX-101.LAB 318336
11 XBRL PRESENTATION FILE gnbt-20191031_pre.xml EX-101.PRE 291176
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 191288115
SIC: 2834 Pharmaceutical Preparations